Arthneeti

Bijoy Hans Share Price & Earnings Call Analysis

₹119.00+0.89% today
Market cap
₹571 Cr
P/E
373.50
ROE
2.70%
Price to sales
62.72
Debt to equity
0.78
52W high / low
₹145 / ₹47.7
EBITDA margin
8.12%
Net profit margin
9.88%
Promoter holding
28.33%
Sales (last year)
₹9 Cr

Incorporated in 1985, Bijoy Hans Ltd offers medical and lifestyle solutions through physical infrastructure and digital platforms.[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Commercial Services & Supplies
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Arvaya Healthcare rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Commercial Services & Supplies companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹2,211 Cr145.7
240%+Up 2%+₹39 Cr6.2
340%+Flat₹500 Cr36.0
440%+Flat₹102 Cr10.4
520–40%Up 2%+₹3,079 Cr36.3
620–40%Up 0–2%₹44 Cr3.9

Sign up free to see every company in the sector ranking and track Arvaya Healthcare.

Pro shows every company guiding 40%+ revenue growth →Full Commercial Services & Supplies ranking

Arvaya Healthcare announcements

All announcements →

Financials of Arvaya Healthcare

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Arvaya Healthcare

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +0.090.080.070.070.070.070.090.060.130.000.000.000.00
Expenses +0.150.370.180.160.140.260.190.230.200.190.280.330.21
Operating Profit-0.06-0.29-0.11-0.09-0.07-0.19-0.10-0.17-0.07-0.19-0.28-0.33-0.21
OPM %-66.67%-362.50%-157.14%-128.57%-100.00%-271.43%-111.11%-283.33%-53.85%
Other Income +0.030.050.120.050.050.080.060.040.610.050.030.020.05
Interest0.000.010.000.000.000.010.000.000.000.010.000.000.00
Depreciation0.010.030.020.020.020.000.010.010.010.000.000.000.00
Profit before tax-0.04-0.28-0.01-0.06-0.04-0.12-0.05-0.140.53-0.15-0.25-0.31-0.16
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%40.00%0.00%0.00%0.00%
Net Profit +-0.04-0.28-0.01-0.05-0.04-0.13-0.05-0.140.53-0.21-0.25-0.31-0.16
EPS in Rs-0.13-0.93-0.03-0.17-0.13-0.43-0.17-0.471.77-0.70-0.33-0.41-0.21

Financials of Arvaya Healthcare

Profit & Loss

Annual income statement trend

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +0.330.350.421.330.440.400.490.400.330.300.280.280.00
Expenses +0.520.560.671.610.720.650.740.660.630.820.640.791.01
Operating Profit-0.19-0.21-0.25-0.28-0.28-0.25-0.25-0.26-0.30-0.52-0.36-0.51-1.01
OPM %-57.58%-60.00%-59.52%-21.05%-63.64%-62.50%-51.02%-65.00%-90.91%-173.33%-128.57%-182.14%
Other Income +0.300.290.270.230.250.230.240.210.150.140.300.740.15
Interest0.000.000.000.000.010.000.000.000.000.010.010.010.01
Depreciation0.080.090.070.070.080.060.050.040.030.060.050.020.00
Profit before tax0.03-0.01-0.05-0.12-0.12-0.08-0.06-0.09-0.18-0.45-0.120.20-0.87
Tax %0.00%-100.00%0.00%0.00%-8.33%0.00%0.00%0.00%0.00%0.00%0.00%30.00%
Net Profit +0.040.00-0.05-0.13-0.11-0.08-0.05-0.09-0.19-0.44-0.120.14-0.93
EPS in Rs0.130.00-0.17-0.43-0.37-0.27-0.17-0.30-0.63-1.47-0.400.47-1.65
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials of Arvaya Healthcare

Balance Sheet

Capital structure and asset base

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital3.003.003.003.003.003.003.003.003.003.003.003.007.50
Reserves1.751.751.701.481.361.281.231.140.950.510.390.531.09
Borrowings +0.000.000.000.090.060.020.000.000.000.080.060.000.00
Other Liabilities +0.100.020.020.030.020.030.040.030.040.040.040.060.07
Total Liabilities4.854.774.724.604.444.334.274.173.993.633.493.598.66
Fixed Assets +0.950.870.860.910.880.820.780.740.710.760.400.000.00
CWIP0.000.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.240.190.190.090.120.050.050.050.140.200.380.130.13
Other Assets +3.663.713.673.603.443.463.443.383.142.672.713.468.53
Total Assets4.854.774.724.604.444.334.274.173.993.633.493.598.66

Financials of Arvaya Healthcare

Cash Flows

Operating, investing and financing cash movement

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +-0.090.13-0.15-0.40-0.100.02-0.07-0.01-0.37-0.26-0.290.22
Cash from Investing Activity +0.040.01-0.06-0.12-0.040.00-0.010.000.00-0.110.320.92
Cash from Financing Activity +0.000.000.000.090.000.00-0.020.000.000.08-0.02-0.06
Net Cash Flow-0.050.14-0.22-0.43-0.140.03-0.10-0.02-0.37-0.290.011.08
Free Cash Flow-0.090.12-0.21-0.52-0.160.02-0.08-0.01-0.37-0.370.031.14
CFO/OP47%-62%60%143%36%-8%28%4%123%50%81%-49%

Financials of Arvaya Healthcare

Ratios

Working capital efficiency and return ratios

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days110.6183.4360.8330.1982.9591.25126.63118.6288.48109.50104.290.00
Inventory Days104.29116.80130.3651.68105.97102.2057.03121.67111.0969.5286.900.00
Days Payable34.7629.2026.079.6923.5529.2045.6236.5063.4869.520.00
Cash Conversion Cycle180.13171.03165.1272.18165.37164.25138.04203.79136.09109.50191.190.00
Working Capital Days575.15521.43582.26255.23796.36894.25513.98438.00940.15206.83234.64273.75
ROCE %-0.21%-0.84%-1.27%-2.59%-2.89%-1.83%-1.41%-2.15%-4.45%-11.67%-7.10%-10.60%
87out of 100

Momentum score · price trend

87 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+147.2%96%
Last 6 months+113.6%98%
Last 3 months−8.5%49%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Arvaya Healthcare: 0.4 × 96 + 0.4 × 98 + 0.2 × 49 = 87.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

Others in Commercial Services & Supplies this season

  • Indiqube Spaces Ltd (Q2 FY27)

    Q2 FY27 revenue from operations: ₹472 crore, up 34% YoY (₹350 crore in Q2 FY26) [Page 29, 9] . Key investor presentation takeaways from Indiqube Spaces Ltd's Q2

  • EFC (I) (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹332.0 crore, up 30% year-on-year (Page 6, 36). Key investor presentation takeaways from EFC (I) Ltd's Q2 FY27 investor present

  • Goyal Aluminiums (Q2 FY27)

    Capex: INR 97 crore (approximate). Key results statement takeaways from Goyal Aluminiums Ltd's Q2 FY27 results statement — and how it ranks against sector peers

  • Transwind Infrastructures (Q2 FY27)

    776.92 lakhs (~68.2% growth). Key results statement takeaways from Transwind Infrastructures Ltd's Q2 FY27 results statement — and how it ranks against sector p

Compare:vs Redingtonvs Firstsource Solutionsvs International Gemological Institute Limited